Researchers identify nerve-guiding protein that aids pancreatic cancer spread

(Johns Hopkins Medicine) Scientists at the Johns Hopkins Kimmel Cancer Center have identified a molecular partnership in pancreatic cancer cells that might help to explain how the disease spreads -- metastasizes -- in some cases. Their findings reveal urgently needed new targets to treat pancreatic cancer, which strikes nearly 50,000 people in the US each year and has only a 5 percent survival rate five years after diagnosis.